Last 7 days
-1.8%
Last 30 days
-6.7%
Last 90 days
17.7%
Trailing 12 Months
-68.3%
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 61.4% | 608,181,000 | 376,860,000 | 260,277,000 | 143,694,000 | 27,111,000 |
S&GA Expenses | -3.4% | 734,574,000 | 760,704,000 | 835,522,000 | 743,982,000 | 652,475,000 |
R&D Expenses | 7.6% | 821,512,000 | 763,824,000 | 792,471,000 | 768,892,000 | 750,185,000 |
EBITDA | 31.3% | -1,273,485,000 | -1,853,164,000 | -1,855,130,000 | -1,868,359,666 | - |
EBITDA Margin | 57.4% | -2.09 | -4.92 | -7.13 | -68.92 | - |
Earnings Before Taxes | 30.5% | -1,304,081,000 | -1,876,934,000 | -1,871,363,000 | -1,912,727,000 | -2,579,712,000 |
EBT Margin | 56.9% | -2.14 | -4.98 | -7.19 | -70.55 | - |
Interest Expenses | 28.7% | 30,596,000 | 23,770,000 | 16,233,000 | 9,074,000 | 1,374,000 |
Net Income | 30.8% | -1,300,000,000 | -1,877,492,000 | -1,871,794,000 | -1,913,095,000 | -2,579,761,000 |
Net Income Margin | 57.1% | -2.14 | -4.98 | -7.19 | -70.57 | - |
Free Cahsflow | -21.6% | -3,301,110,000 | -2,714,417,000 | -1,983,726,000 | -1,747,122,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 14.4% | 7,879 | 6,888 | 7,129 | 7,402 | 7,882 |
Current Assets | 18.2% | 4,912 | 4,156 | 4,966 | 5,864 | 6,507 |
Cash Equivalents | 37.3% | 1,736 | 1,264 | 3,157 | 5,392 | 6,263 |
Inventory | 21.8% | 834 | 685 | 553 | 334 | 127 |
Liabilities | -3.5% | 3,530 | 3,657 | 3,419 | 3,572 | 3,972 |
Current Liabilities | 13.6% | 938 | 825 | 654 | 512 | 396 |
. Short Term Borrowings | 449.6% | 14.00 | 2.00 | 4.00 | 15.00 | - |
LT Debt, Non Current | 0.1% | 1,992 | 1,991 | 1,989 | 1,988 | 1,987 |
Shareholder's Equity | 34.6% | 4,350 | 3,231 | 3,710 | 3,829 | 3,909 |
Retained Earnings | -6.9% | -7,370 | -6,897 | -6,400 | -6,147 | -6,065 |
Additional Paid-In Capital | 15.6% | 11,752 | 10,163 | 10,099 | 9,997 | 9,996 |
Shares Outstanding | 8.9% | 1,829 | 1,680 | 1,673 | 1,667 | 1,648 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -17.8% | -2,226 | -1,890 | -1,612 | -1,334 | -1,058 |
Share Based Compensation | -15.8% | 424 | 503 | 656 | 587 | 517 |
Cashflow From Investing | -8.0% | -3,681 | -3,410 | -2,128 | -511 | -420 |
Cashflow From Financing | -22.3% | 1,347 | 1,734 | 6,341 | 6,438 | 7,136 |
Buy Backs | -100.0% | 0.00 | 21.00 | - | - | - |
82.7%
82.7%
82.7%
Y-axis is the maximum loss one would have experienced if Lucid Group was unfortunately bought at previous high price.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-23 | MetLife Investment Management, LLC | reduced | -2.5 | -231,305 | 210,692 | -% |
2023-03-17 | American Portfolios Advisors | added | 1.57 | -89,796 | 429,019 | 0.02% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | added | 52.92 | -103,261 | 301,739 | 0.01% |
2023-03-13 | Claro Advisors LLC | reduced | -6.67 | -128,968 | 76,032 | 0.03% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -5.34 | -6,006,280 | 5,174,720 | 0.01% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -37.2 | -695,000 | 308,000 | -% |
2023-03-02 | OLIVER LAGORE VANVALIN INVESTMENT GROUP | unchanged | - | -8,350 | 7,650 | -% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 1,366 | 1,366 | -% |
2023-02-28 | Voya Investment Management LLC | added | - | -1,507,110 | 1,441,890 | -% |
2023-02-27 | Parallax Volatility Advisers, L.P. | reduced | -28.11 | -758,561 | 411,439 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Dec 28, 2022 | ayar third investment co | 60.66% | 1,109,006,595 | SC 13D/A | |
Nov 15, 2022 | ayar third investment co | 60.4% | 1,015,252,523 | SC 13D/A | |
Feb 14, 2022 | aristeia capital llc | 0% | 0 | SC 13G/A | |
Feb 14, 2022 | glazer capital, llc | 0.0% | 0 | SC 13G/A | |
Feb 11, 2022 | churchill sponsor iv llc | 5.7% | 96,100,000 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 0.60 -92.54% | 0.67 -91.67% | 0.92 -88.56% | 1.35 -83.21% | 2.20 -72.64% |
Current Inflation | 0.59 -92.66% | 0.65 -91.92% | 0.88 -89.05% | 1.25 -84.45% | 1.98 -75.37% |
Very High Inflation | 0.59 -92.66% | 0.64 -92.04% | 0.83 -89.68% | 1.13 -85.95% | 1.72 -78.61% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 28, 2023 | 8-K | Current Report | |
Mar 13, 2023 | DEF 14A | DEF 14A | |
Mar 13, 2023 | DEFA14A | DEFA14A | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | PRE 14A | PRE 14A | |
Mar 03, 2023 | 8-K | Current Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-05 | House Sherry Ann | sold (taxes) | -276,711 | 8.94 | -30,952 | chief financial officer |
2023-03-05 | Dhingra Gagan | sold (taxes) | -50,359 | 8.94 | -5,633 | vp of acctng & internal ctrl |
2023-03-05 | Rawlinson Peter Dore | sold (taxes) | -4,175,360 | 8.94 | -467,042 | ceo & chief technology officer |
2023-03-05 | Bach Eric | sold (taxes) | -298,256 | 8.94 | -33,362 | svp, product & chief engineer |
2023-03-05 | Bell Michael | sold (taxes) | -477,298 | 8.94 | -53,389 | senior vice president, digital |
2022-12-29 | Rawlinson Peter Dore | acquired | 321,741 | 0.37 | 869,570 | ceo & chief technology officer |
2022-12-22 | PUBLIC INVESTMENT FUND | bought | 915,000,000 | 10.6752 | 85,712,700 | - |
2022-12-07 | Bell Michael | sold | -107,716 | 8.5666 | -12,574 | senior vice president, digital |
2022-12-05 | House Sherry Ann | sold (taxes) | -310,560 | 10.15 | -30,597 | chief financial officer |
2022-12-05 | Bach Eric | sold (taxes) | -334,889 | 10.15 | -32,994 | svp, product & chief engineer |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue | $ 608,181 | $ 27,111 | $ 3,976 |
Costs and expenses | |||
Cost of revenue | 1,646,086 | 154,897 | 3,070 |
Research and development | 821,512 | 750,185 | 511,110 |
Selling, general and administrative | 734,574 | 652,475 | 89,023 |
Total cost and expenses | 3,202,172 | 1,557,557 | 603,203 |
Loss from operations | (2,593,991) | (1,530,446) | (599,227) |
Other income (expense), net | |||
Change in fair value of forward contracts | 0 | (454,546) | (118,382) |
Transaction costs expensed | 0 | (2,717) | 0 |
Interest income | 56,756 | 0 | 0 |
Interest expense | (30,596) | (1,374) | (64) |
Other income (expense), net | 9,532 | (893) | (690) |
Total other income (expense), net | 1,289,910 | (1,049,266) | (120,341) |
Loss before provision for (benefit from) income taxes | (1,304,081) | (2,579,712) | (719,568) |
Provision for (benefit from) income taxes | 379 | 49 | (188) |
Net loss | (1,304,460) | (2,579,761) | (719,380) |
Deemed dividend related to the issuance of Series E convertible preferred stock | 0 | (2,167,332) | 0 |
Net loss attributable to common stockholders, basic | (1,304,460) | (4,747,093) | (705,596) |
Change in fair value of dilutive warrants | (1,254,218) | 0 | 0 |
Net loss attributable to common stockholders, diluted | $ (2,558,678) | $ (4,747,093) | $ (705,596) |
Weighted average shares outstanding used in computing net loss per share attributable to common stockholders, basic (in shares) | 1,678,346,079 | 740,393,759 | 24,825,944 |
Weighted average shares outstanding used in computing net loss per share attributable to common stockholders, diluted (in shares) | 1,693,258,608 | 740,393,759 | 24,825,944 |
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.78) | $ (6.41) | $ (28.42) |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (1.51) | $ (6.41) | $ (28.42) |
Other comprehensive loss | |||
Net unrealized losses on investments, net of tax | $ (11,572) | $ 0 | $ 0 |
Comprehensive loss | (1,316,032) | (2,579,761) | (719,380) |
Deemed dividend related to the issuance of Series E convertible preferred stock | 0 | (2,167,332) | 0 |
Comprehensive loss attributable to common stockholders | (1,316,032) | (4,747,093) | (705,596) |
Series B | |||
Other income (expense), net | |||
Deemed contribution related to repurchase of convertible preferred stock | 0 | 0 | 1,000 |
Other comprehensive loss | |||
Deemed contribution related to repurchase of convertible preferred stock | 0 | 0 | 1,000 |
Series C | |||
Other income (expense), net | |||
Deemed contribution related to repurchase of convertible preferred stock | 0 | 0 | 12,784 |
Other comprehensive loss | |||
Deemed contribution related to repurchase of convertible preferred stock | 0 | 0 | 12,784 |
Change in fair value of convertible preferred stock warrant liability | |||
Other income (expense), net | |||
Change in fair value of stock warrants liability | 0 | (6,976) | (1,205) |
Change in fair value of common stock warrant liability | |||
Other income (expense), net | |||
Change in fair value of stock warrants liability | $ 1,254,218 | $ (582,760) | $ 0 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,735,765 | $ 6,262,905 |
Short-term investments | 2,177,231 | 0 |
Accounts receivable, net | 19,542 | 3,148 |
Inventory | 834,401 | 127,250 |
Prepaid expenses | 63,548 | 70,346 |
Other current assets | 81,541 | 43,328 |
Total current assets | 4,912,028 | 6,506,977 |
Property, plant and equipment, net | 2,166,776 | 1,182,153 |
Right-of-use assets | 215,160 | 161,974 |
Long-term investments | 529,974 | 0 |
Other noncurrent assets | 55,300 | 30,609 |
TOTAL ASSETS | 7,879,238 | 7,881,713 |
Current liabilities: | ||
Accounts payable | 229,084 | 41,342 |
Accrued compensation | 63,322 | 32,364 |
Finance lease liabilities, current portion | 10,586 | 4,183 |
Other current liabilities | 634,567 | 318,212 |
Total current liabilities | 937,559 | 396,101 |
Finance lease liabilities, net of current portion | 81,336 | 6,083 |
Common stock warrant liability | 140,590 | 1,394,808 |
Long-term debt | 1,991,840 | 1,986,791 |
Other long-term liabilities | 378,212 | 188,575 |
Total liabilities | 3,529,537 | 3,972,358 |
Commitments and contingencies (Note 15) | ||
STOCKHOLDERS’ EQUITY | ||
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of December 31, 2022 and 2021; no shares issued and outstanding as of December 31, 2022 and 2021 | 0 | 0 |
Common stock, par value $0.0001; 15,000,000,000 shares authorized as of December 31, 2022 and 2021; 1,830,172,561 and 1,648,413,415 shares issued and 1,829,314,736 and 1,647,555,590 shares outstanding as of December 31, 2022 and 2021, respectively | 183 | 165 |
Additional paid-in capital | 11,752,138 | 9,995,778 |
Treasury stock, at cost, 857,825 shares at December 31, 2022 and 2021 | (20,716) | (20,716) |
Accumulated other comprehensive loss | (11,572) | 0 |
Accumulated deficit | (7,370,332) | (6,065,872) |
Total stockholders’ equity | 4,349,701 | 3,909,355 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 7,879,238 | $ 7,881,713 |